Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta

by Bustamante, Marta F., Nurtdinov, Ramil N., Río, Jordi, Montalban, Xavier, Comabella, Manuel
Published 2013

Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis

by Arrambide, Georgina, Espejo, Carmen, Yarden, Jennifer, Fire, Ella, Spector, Larissa, Dotan, Nir, Dukler, Avinoam, Rovira, Alex, Montalban, Xavier, Tintore, Mar
Published 2013

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis

by Malhotra, Sunny, Fissolo, Nicolas, Tintoré, Mar, Wing, Ana Cristina, Castilló, Joaquin, Vidal-Jordana, Angela, Montalban, Xavier, Comabella, Manuel
Published 2015

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis

by Fissolo, Nicolás, Costa, Carme, Nurtdinov, Ramil N, Bustamante, Marta F, Llombart, Victor, Mansilla, María J, Espejo, Carmen, Montalban, Xavier, Comabella, Manuel
Published 2012

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE

by Marín, Nieves, Mecha, Miriam, Espejo, Carmen, Mestre, Leyre, Eixarch, Herena, Montalban, Xavier, Álvarez-Cermeño, José C., Guaza, Carmen, Villar, Luisa M.
Published 2014

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

by Cohen, Jeffrey A, Khatri, Bhupendra, Barkhof, Frederik, Comi, Giancarlo, Hartung, Hans-Peter, Montalban, Xavier, Pelletier, Jean, Stites, Tracy, Ritter, Shannon, von Rosenstiel, Philipp, Tomic, Davorka, Kappos, Ludwig
Published 2016

Predictive value of early brain atrophy on response in patients treated with interferon β

by Pérez-Miralles, Francisco Carlos, Sastre-Garriga, Jaume, Vidal-Jordana, Angela, Río, Jordi, Auger, Cristina, Pareto, Deborah, Tintoré, Mar, Rovira, Alex, Montalban, Xavier
Published 2015

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling

by Valverde, Sergi, Oliver, Arnau, Roura, Eloy, Pareto, Deborah, Vilanova, Joan C., Ramió-Torrentà, Lluís, Sastre-Garriga, Jaume, Montalban, Xavier, Rovira, Àlex, Lladó, Xavier
Published 2015

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis

by Cantó, Ester, Tintoré, Mar, Villar, Luisa Maria, Borrás, Eva, Álvarez-Cermeño, Jose Carlos, Chiva, Cristina, Sabidó, Eduard, Rovira, Alex, Montalban, Xavier, Comabella, Manuel
Published 2014

Hsp70 Regulates Immune Response in Experimental Autoimmune Encephalomyelitis

by Mansilla, M. José, Costa, Carme, Eixarch, Herena, Tepavcevic, Vanja, Castillo, Mireia, Martin, Roland, Lubetzki, Catherine, Aigrot, Marie-Stéphane, Montalban, Xavier, Espejo, Carmen
Published 2014

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study

by Gold, Ralf, Radue, Ernst-Wilhelm, Giovannoni, Gavin, Selmaj, Krzysztof, Havrdova, Eva, Stefoski, Dusan, Sprenger, Till, Montalban, Xavier, Cohan, Stanley, Umans, Kimberly, Greenberg, Steven J., Ozen, Gulden, Elkins, Jacob
Published 2016

Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis

by Malhotra, Sunny, Bustamante, Marta F., Pérez-Miralles, Francisco, Rio, Jordi, Ruiz de Villa, Mari Carmen, Vegas, Esteban, Nonell, Lara, Deisenhammer, Florian, Fissolo, Nicolás, Nurtdinov, Ramil N., Montalban, Xavier, Comabella, Manuel
Published 2011

Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods

by Baranzini, Sergio E, Mousavi, Parvin, Rio, Jordi, Caillier, Stacy J, Stillman, Althea, Villoslada, Pablo, Wyatt, Matthew M, Comabella, Manuel, Greller, Larry D, Somogyi, Roland, Montalban, Xavier, Oksenberg, Jorge R
Published 2005

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

by Penner, Iris-Katharina, Stemper, Brigitte, Calabrese, Pasquale, Freedman, Mark S, Polman, Chris H, Edan, Gilles, Hartung, Hans-Peter, Miller, David H, Montalbán, Xavier, Barkhof, Frederik, Pleimes, Dirk, Lanius, Vivian, Pohl, Christoph, Kappos, Ludwig, Sandbrink, Rupert
Published 2012

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

by Jarius, Sven, Kleffner, Ilka, Dörr, Jan M, Sastre-Garriga, Jaume, Illes, Zsolt, Eggenberger, Eric, Chalk, Colin, Ringelstein, Marius, Aktas, Orhan, Montalban, Xavier, Fechner, Kai, Stöcker, Winfried, Ringelstein, Erich B, Paul, Friedemann, Wildemann, Brigitte
Published 2014

MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study

by Fox, Robert J., Cree, Bruce A.C., De Sèze, Jerome, Gold, Ralf, Hartung, Hans-Peter, Jeffery, Douglas, Kappos, Ludwig, Kaufman, Michael, Montalbán, Xavier, Weinstock-Guttman, Bianca, Anderson, Britt, Natarajan, Amy, Ticho, Barry, Duda, Petra
Published 2014

Ancient and Recent Selective Pressures Shaped Genetic Diversity at AIM2-Like Nucleic Acid Sensors

by Cagliani, Rachele, Forni, Diego, Biasin, Mara, Comabella, Manuel, Guerini, Franca R., Riva, Stefania, Pozzoli, Uberto, Agliardi, Cristina, Caputo, Domenico, Malhotra, Sunny, Montalban, Xavier, Bresolin, Nereo, Clerici, Mario, Sironi, Manuela
Published 2014

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment

by Tur, Carmen, Tintoré, Mar, Vidal-Jordana, Ángela, Bichuetti, Denis, Nieto González, Pablo, Arévalo, María Jesús, Arrambide, Georgina, Anglada, Elisenda, Galán, Ingrid, Castilló, Joaquín, Nos, Carlos, Río, Jordi, Martín, María Isabel, Comabella, Manuel, Sastre-Garriga, Jaume, Montalban, Xavier
Published 2013

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

by Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Published 2016

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

by Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka
Published 2015